Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
Authors:
Open Access
- 21 October 2019
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 20 (1) , 1-8
Abstract
Background: Giant cell tumor of the tendon sheath is the most common form of giant cell tumors and is the second most common soft tissue tumor of the hand region after ganglion cyst. Magnetic resonance imaging is the diagnostic tool of choice for both diagnosis and treatment planning. The current standard treatment of choice is simple excision. The main concern about the treatment is related to the high recurrence rates. Besides incomplete excision, there is no consensus concerning the effect of other risk factors on recurrence. The literature lacks detailed reports on surgical excision of these tumors with a standardized surgical treatment and an appropriate patient follow up. The aim of this study was to investigate the recurrence rate and the associated recurrence risk factors for giant cell tumor of tendon sheath of the hand following a standardized treatment. Methods: The records of patients treated for giant cell tumor of tendon sheath of the hand treated by the same hand surgeon were evaluated retrospectively. The features obtained from preoperative magnetic resonance imaging, final physical examination, patients’ age and sex, anatomical site of the tumor, relationship of the tumor with bone, joint or neurovascular structures, bone invasion, recurrence after surgery and complications like skin necrosis, digital neuropathy or limitation in range of motion were documented. Chi-square test was used to compare categorical variables. Results: Fifty patient were included in the study. The average follow-up time was 84 months. Three recurrences (6%) were recorded. The only significant risk factor for the recurrence was tumor adjacency to the interphalangeal joints of the fingers other than thumb. No major or minor complications were encountered in the postoperative period. Conclusion: With adequate surgical exposure and meticulous dissection provided by the magnification loupes, we were able demonstrate one of the lowest recurrence rates in the literature. Well-designed studies combining the recurrence rates of several hand surgery centers implementing a standardized treatment are needed to better demonstrate the associated risk factors for recurrence.Keywords
This publication has 27 references indexed in Scilit:
- Tenosynovial Giant Cell Tumor: Case Report and ReviewArchives of Pathology & Laboratory Medicine, 2012
- Giant Cell Tumour of Tendon Sheath of the Digits. A Systematic ReviewHAND, 2011
- Recurrence of Giant Cell Tumors in the Hand: A Prospective StudyThe Journal of Hand Surgery, 2010
- Les tumeurs à cellules géantes des gaines synoviales de la main: à propos de 32 casChirurgie de la Main, 2007
- Giant cell tumour in the tendon sheath of the hand: Importance of the type of lesionScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 2007
- The Effect of Cellular Proliferative Activity on Recurrence and Local Tumour Extent of Localized Giant Cell Tumour of Tendon SheathJournal of Hand Surgery (European Volume), 2004
- Giant Cell Tumours of Tendon Sheath: Classification and Recurrence RateJournal of Hand Surgery (European Volume), 2001
- PIGMENTED VILLONODULAR SYNOVITIS OF THE HAND IN THE ASIAN POPULATIONHand Surgery, 1999
- Pigmented Villonodular Synovitis of the HandHand, 1980
- Benign giant-cell synovioma. An investigation of 85 casesBritish Journal of Surgery, 1951